---
title: "Lilly's Taltz (Ixekizumab) And Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy In First-Of-Its-Kind Phase 3B Trial"
type: "News"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/news/276223647.md"
datetime: "2026-02-18T11:59:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276223647.md)
  - [en](https://longbridge.com/en/news/276223647.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276223647.md)
---

> 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/276223647.md) | [English](https://longbridge.com/en/news/276223647.md)


# Lilly's Taltz (Ixekizumab) And Zepbound (Tirzepatide) Used Together Delivered Superior Efficacy In First-Of-Its-Kind Phase 3B Trial

Feb 18 (Reuters) - Eli Lilly and Co (LLY.N) : \* LILLY'S TALTZ (IXEKIZUMAB) AND ZEPBOUND (TIRZEPATIDE) USED TOGETHER DELIVERED SUPERIOR EFFICACY IN FIRST-OF-ITS-KIND PHASE 3B TRIAL FOR ADULTS WITH PSORIASIS AND OBESITY OR OVERWEIGHT Source text: Further company coverage: (LLY.N)

### 相關股票

- [Defiance Daily Target 2X Long LLY ETF (LLYX.US)](https://longbridge.com/zh-HK/quote/LLYX.US.md)
- [Health Care Select Sector SPDR (XLV.US)](https://longbridge.com/zh-HK/quote/XLV.US.md)
- [Eli Lilly (LLY.US)](https://longbridge.com/zh-HK/quote/LLY.US.md)
- [iShares Biotechnology ETF (IBB.US)](https://longbridge.com/zh-HK/quote/IBB.US.md)
- [First Trust NYSE Arca Biotech Index Fd (FBT.US)](https://longbridge.com/zh-HK/quote/FBT.US.md)
- [iShares US Pharma (IHE.US)](https://longbridge.com/zh-HK/quote/IHE.US.md)
- [SPDR S&P Biotech (XBI.US)](https://longbridge.com/zh-HK/quote/XBI.US.md)
- [Ark Genomic Revolution ETF (ARKG.US)](https://longbridge.com/zh-HK/quote/ARKG.US.md)
- [Invesco Biotechnology & Genome ETF (PBE.US)](https://longbridge.com/zh-HK/quote/PBE.US.md)
- [ALPS Medical Breakthrough (SBIO.US)](https://longbridge.com/zh-HK/quote/SBIO.US.md)
- [VG Health (VHT.US)](https://longbridge.com/zh-HK/quote/VHT.US.md)
- [Invesco Nasdaq Biotechnology ETF (IBBQ.US)](https://longbridge.com/zh-HK/quote/IBBQ.US.md)
- [VanEck Biotech ETF (BBH.US)](https://longbridge.com/zh-HK/quote/BBH.US.md)
- [Proshares Ultra Nasdaq Biotech (BIB.US)](https://longbridge.com/zh-HK/quote/BIB.US.md)
- [Direxion Daily LLY Bull 2X Shares (ELIL.US)](https://longbridge.com/zh-HK/quote/ELIL.US.md)

## 相關資訊與研究

- [Eli Lilly: Foundayo will be available with prescriptions accepted immediately and shipping from April 6](https://longbridge.com/zh-HK/news/281395595.md)
- [ADVISORY-Alert wrongly tagged to Rubicon Organics withdrawn](https://longbridge.com/zh-HK/news/281559383.md)
- [Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders | LLY Stock News](https://longbridge.com/zh-HK/news/281171668.md)
- [<![CDATA[Eli Lilly Enters $7.8 Billion Agreement to Acquire Centessa Pharmaceuticals to Advance Sleep-Wake Treatments]]>](https://longbridge.com/zh-HK/news/281203519.md)
- [Eli Lilly pushes for NHS drug price increases in return for its UK investment, FT reports](https://longbridge.com/zh-HK/news/280952509.md)